We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MARK:QSEAlRayan Bank Analysis

Data as of 2026-05-18 - not real-time

$0.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Remark Holdings (MARK) is trading at a fraction of a cent, with the price sitting just above the identified support level. The 20‑day and 50‑day SMAs are tightly clustered, indicating a flat price action, while the 200‑day SMA sits well above current levels, underscoring a long‑term downtrend. RSI is near the 50‑point midpoint, suggesting neutral momentum, and the MACD histogram remains negative, reinforcing a bearish bias. Volume has been trending upward, yet the market cap remains minuscule, highlighting severe liquidity constraints.
On the fundamentals side, the company reports negative operating margins, zero earnings per share and a trailing PE that is effectively non‑existent, reflecting ongoing profitability challenges. Debt vastly exceeds cash on hand and the balance sheet shows a negative book value per share, which together raise solvency concerns. Despite a DCF‑derived fair value that is orders of magnitude higher than the market price, the underlying cash‑flow profile is weak, with negative operating cash flow and only modest free‑cash‑flow generation. The sector—software infrastructure—carries a high growth narrative, but MARK’s financials align more with a distressed value play. Extreme market sentiment, as indicated by an “Extreme Greed” reading, may be inflating speculative interest despite the underlying risk. Overall, the combination of high short‑term volatility, low beta, and a near‑zero dividend further limits the investment case.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish MACD histogram
  • Price near support with limited upside
  • Severe liquidity constraints

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside if DCF assumptions materialize
  • Continued negative earnings risk
  • Sector growth narrative

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative cash flows
  • High debt relative to cash
  • Unlikely dividend or earnings recovery

Key Metrics & Analysis

Financial Health

Revenue Growth74.90%
P/E Ratio-0.0
ROA-130.19%
P/B Ratio-0.0
Op. Cash Flow$-8406000
Free Cash Flow$12.7M
Industry P/E38.6

Technical Analysis

TrendNeutral
RSI49.4
Support$0.00
Resistance$0.00
MA 20$0.00
MA 50$0.00
MA 200$0.00
MACDBearish
VolumeIncreasing
Fear & Greed Index88.25

Valuation

Fair Value$7.05
GradeUndervalued
TypeValue

Risk Assessment

Beta0.87
Volatility594.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.